Uwe Siebert

Adjunct Professor of Health Policy and Management

Department of Health Policy and Management

Department of Health Policy and Management

718 Huntington Avenue
2nd Floor
Boston, Massachusetts 02115

Biosketch

Prof. Uwe Siebert, MD, MPH, MSc, ScD, Professor of Public Health, is the
Chair of the Department of Public Health, Medical Decision Making and Health
Technology Assessment at the University
of Health Sciences, Medical
Informatics and Technology (UMIT) in Austria.
He is also Adjunct
Professor of Health Policy and Management at Harvard School of Public
Health. He directs the Program on Cardiovascular Research at the
Institute for
Technology Assessment, Massachusetts General
Hospital, Boston. He has an adjunct teaching appointment
at the School of Public
Health and Epidemiology at the University of Munich.

    After medical school, Prof. Siebert worked for several years as a physician
in international public health projects. He then earned an MPH at the Munich School of Public Health, and
completed an MSc in Epidemiology and an ScD in Health Policy and Management
with a concentration in decision sciences at the Harvard School of Public
Health. Before he started his faculty position at Harvard
Medical School,
he was the Director of the Bavarian Public Health Research and Coordinating Center
at the University of Munich, Germany, and completed Visiting Scholarship at the
Harvard Center for Risk Analysis.

    His research interests include applying decision-analytic modeling,
meta-analysis, quality-of-life assessment and cost-effectiveness analysis in
the framework of health technology assessments (HTA) as well as in the clinical
context of routine health care. His current substantive research focuses on
cardiovascular disease, diabetes, cancer, hepatitis C, HIV, and neurological
disorders. His methodological research is focused on evaluations of public
health interventions, prevention and screening, diagnostic imaging procedures
as well as the development of causal decision models based on complex
longitudinal data with time-varying interventions or exposures.
<>

Prof. Siebert is a member of the Board of Directors of the International
Society for Pharmacoeconomics and Outcomes Research (ISPOR), a member of the
International Expert Committee Advising the Institute for Quality and
Efficiency in Health Care (IQWiG) on the Methods for Economic Evaluations of
Health Care Interventions, and a member of the Advisory Board of the Ludwig
Boltzmann Institute for Health Technology Assessment in Austria. He is the
Chairman of the Working Groups “Health Economics” and “Medical
Decision Making” of the German Society for Medical Informatics, Biometry
and Epidemiology (GMDS). He is the Co-Chair of the “Issues in Methodology
Section” of the Society of Medical Decision Making (SMDM) Policy
Initiative and on the Board of Trustees of SMDM. He teaches courses in decision
analysis, HTA, and advanced epidemiologic methods at several universities and
for industry in Europe and the US.
He advises government agencies, academic institutions and the industry
regarding the conduction and impact of health technology assessments on policy
and reimbursement decisions. He has authored more than 150 publications
including HTA reports, textbook chapters for decision analysis, scientific
articles, and editorials.

 

Biosketch

Prof. Uwe Siebert, MD, MPH, MSc, ScD, Professor of Public Health, is the Chair of the Department of Public Health and Health Technology Assessment at UMIT – University for Health Sciences, Medical Informatics and Technology in Austria and the Director of the Division for Public Health Decision Modeling, HTA, and Health Economics in the ONCOTYROL – Center for Personalized Cancer Medicine in Austria. He is also Adjunct Professor of Health Policy and Management at the Harvard School of Public Health and Director of the Program on Cardiovascular Research at the Institute for Technology Assessment and Department of Radiology at the Massachusetts General Hospital, Harvard Medical School, Boston. He has an adjunct teaching appointment at the School of Public Health and Epidemiology at the University of Munich.

After medical school, Prof. Siebert worked for several years as a physician in international public health projects in West-Africa, Brazil, and Germany. He then earned an MPH at the Munich School of Public Health, and completed an MSc in Epidemiology and an ScD in Health Policy and Management with a concentration in decision sciences at the Harvard School of Public Health. Before he started his faculty position at Harvard Medical School, he was the Director of the Bavarian Public Health Research and Coordinating Center at the University of Munich, Germany, and completed Visiting Scholarship at the Harvard Center for Risk Analysis.

Prof. Siebert is Vice President-Elect of the Society of Medical Decision Making (SMDM), a member of the Latin America Consortium Advisory Committee of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), a member of the ‘National HTA Strategy’ Expert Group of the Federal Ministry of Health in Austria, a member of the Advisory Board of the Ludwig Boltzmann Institute for Health Technology Assessment in Austria, a member of the Working Group “Methods of the Assessment of Cost-Benefit Relations” of the Scientific Advisory Board of IQWIG, a member of the Oncology Advisory Council of the Federal Ministry of Health in Austria, a member of the Austrian Cochrane Collaboration Branch, and he has served as a member of the ISPOR Board of Directors, a member of the SMDM Board of Trustees, and a member of the International Expert Committee Advising the Institute for Quality and Efficiency in Health Care (IQWiG) on the Methods for Economic Evaluations of Health Care Interventions.  He is the Chairman of the Working Groups “Health Economics” and “Medical Decision Making” of the German Society for Medical Informatics, Biometry and Epidemiology (GMDS). He is Co-Chair of the ISPOR-SMDM Modeling Good Research Practices Task Force, Co-Chair of the “Issues in Methodology Section” of the SMDM Policy Initiative, and a Leadership Member of the ISPOR Personalized Medicine Special Interest Group. He teaches courses in decision analysis, HTA, economic evaluation, and advanced epidemiologic methods at several universities and for industry in Europe, USA, and South America. He advises government agencies, academic institutions and the industry regarding the conduction and impact of health technology assessments on policy and reimbursement decisions. He has authored more than 250 publications including HTA reports, textbook chapters, scientific articles, and editorials, and is Associate Editor of the International Journal of Public Health as well as editorial board member of several other scientific journals.

Research

 

Prof. Siebert’s research interests include applying decision-analytic modeling, meta-analysis, quality-of-life assessment and cost-effectiveness analysis in the framework of health technology assessments (HTA) as well as in the clinical context of routine health care. His current substantive research focuses on cardiovascular disease, diabetes, cancer, hepatitis C, HIV, and neurological disorders. His methodological research is focused on evaluations of public health interventions, prevention and screening, diagnostic imaging procedures as well as the development of causal decision models based on complex longitudinal data with time-varying interventions or exposures.

Research

His research interests include applying evidence-based quantitative methods from public health, epidemiology, outcomes research, economic evaluation and decision sciences in the framework of health technology assessments (HTA) as well as in the clinical context of routine health care. His current substantive research focuses on cancer, cardiovascular disease, diabetes, hepatitis C, HIV, and neurological disorders. His methodological research is focused on evaluations of public health interventions, prevention and screening, diagnostic imaging procedures, personalized medicine as well as the development of causal decision models.

Education

1980  B.Sc.  Gymnasium Giengen, Germany (Mathematics, Chemistry)
1991  M.D. Ludwig-Maximilians-University of Munich, Germany
1996 Licensure to practice General Medicine, State of Bavaria, Germany 
1996  M.P.H. Postgraduate School of Public Health and Epidemiology, Ludwig-Maximilians-University of Munich, Germany
2000  S.M.  Master of Science in Epidemiology, Harvard School of Public Health, Boston, MA, USA
2002 Board Certificate in Epidemiology, German Society of Medical Informatics, Biostatistics and Epidemiology (GMDS)
2004 Board Certificate in Biostatistics in Medicine, German Society of Medical Informatics, Biostatistics and Epidemiology (GMDS)
2005  S.D. Doctor of Science in Health Policy and Management, Harvard School of Public Health, Boston, MA, USA

Honors and Distinctions

1980 Robert Bosch Science Award
1996 Bavarian Public Health Award
1996 Fritz and Hildegard Berg Award for Public Health
1998 Pain Research Award
1999 Spitzner-Award Physical and Rehabilitative Medicine
1999 Pharmacoepidemiology Training and Research Scholarship, Dept. of Epidemiology, HSPH
1999 Paul Martini Research Award in Pharmacoepidemiology
2000 German Award for Pain Research
2002 Novartis Fellowship Award in the Program on the Economic Evaluation of Medical Technology (PEEMT), Harvard Center for Risk Analysis, HSPH
2003 German Cochrane Center and Deutsche Krankenversicherung (DKV): Award for Evidence-based Medicine
2004 Society of Medical Decision Making: Award for Outstanding Short Course
2004 International Society of Pharmacoeconomics and Outcomes Research: Poster Finalist Award
2008 German Society for Internal Medicine (DGIM): Award for Best Publication in Medizinische Klinik – Journal for Internal Medicine in Hospital and Private Practice 2007
2008 International Society of Pharmacoeconomics and Outcomes Research: Board of Directors Service Award
2009 David Sackett Award, German Network Evidence-Based Medicine
2009 Award for Best Short Course (Society of Medical Decision Making)
2010 SMDM Leadership and Service Award for SMDM Trustee, Methods Policy Liaison & 2010 European Meeting Chair with appreciation for leadership and service 2007-2010
2011 ISPOR Service Award as Co-Chair of the ISPOR-SMDM Modeling Good Research Practices Task Force and Co-Chair of the State-Transition Modeling Working Group